Medicine and Dentistry
Fibroblast Growth Factor 19
100%
Drug Delivery System
100%
FGF21
100%
Clinical Trial
50%
Fibroblast Growth Factor Receptor
33%
Water-Electrolyte Imbalance
16%
Cardiovascular Disease
16%
Disease Activity
16%
Gastrointestinal Distress
16%
Protein Structure
16%
Nonalcoholic Fatty Liver
16%
Genetic Variability
16%
Rodent Study
16%
Maturity Onset Diabetes of the Young
16%
Pharmacology, Toxicology and Pharmaceutical Science
Drug Delivery System
100%
Fibroblast Growth Factor 19
100%
Fibroblast Growth Factor 21
100%
Clinical Trial
50%
Fibroblast Growth Factor Receptor
33%
Preclinical Study
16%
Gastrointestinal Symptom
16%
Disease Activity
16%
Cardiovascular Disease
16%
Nonalcoholic Fatty Liver
16%
Metabolic Disorder
16%
Non Insulin Dependent Diabetes Mellitus
16%
Immunology and Microbiology
Fibroblast Growth Factor 19
100%
Fibroblast Growth Factor 21
100%
Drug Targeting
100%
Fibroblast Growth Factor
33%
Tissue Distribution
33%
Cellular Distribution
16%
Genetic Variability
16%
Protein Structure
16%
Non-Alcoholic Fatty Liver Disease
16%
Preclinical Study
16%
